Switzerland
-
WHO report warns smoking increases infertility risk in women by 40 percent
A systematic review of studies published between 2000 and 2026 found that women who currently smoke tobacco have a 40% higher risk of infertility than women who do not smoke.
-
Global Initiative establishes dedicated Mpox vaccine reserve to aid rapid response
The new stockpile builds on the Access and Allocation Mechanism established in 2024 during the mpox Public Health Emergency of International Concern (PHEIC).
-
WHO issues emergency guidance on Ervebo use during Bundibugyo virus outbreaks
The guidance recommends that Ervebo® should currently be used against Bundibugyo virus (BDBV) only within a research protocol.
-
Philips expands connected patient monitoring ecosystem with six technology partnerships
The partnerships will enable healthcare providers to integrate wearable and out-of-hospital monitoring technologies into the Philips ecosystem.
-
Polaroid Therapeutics joins Crohn’s & Colitis Foundation’s IBD Plexus to advance IBD research
Through its membership, PTx will gain access to longitudinal health data and biosamples from people living with IBD, with personal identifying information removed.
-
WHO issues first comprehensive clinical guidelines for flavovirus care amid ongoing Bundibugyo outbreak
The new framework sets out 16 evidence-based recommendations designed to strengthen patient care and improve survival rates during outbreaks.
-
Gavi mobilizes US$50M First Response Fund to fight Bundibugyo Ebola outbreak
The initiative will also involve coordination with World Health Organization, Africa Centres for Disease Control and Prevention, and UNICEF to ensure alignment with national outbreak response plans and immunization priorities.
-
Africa CDC signs landmark health sovereignty agreement with the Global Fund at WHA79
The partnership builds on Africa CDC’s recent efforts to accelerate the deployment of community health workers across the continent through collaborations with regional partners.
-
WHO renews five-year partnership with Gilead Sciences to eliminate deadly Kala-Azar disease
Since the partnership began, Gilead has supplied more than 1.1 million vials of AmBisome and contributed over US$18 million in funding.
-
SERB Pharmaceuticals acquires rights to Idefirix in US$133.6M deal with Hansa Biopharma
Idefirix is a first-in-class treatment designed to help highly sensitised adult kidney transplant patients who face difficulties finding compatible donors.